Global Polio Vaccine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

SKU ID : GIR- 13080162

Publishing Date : 11-Feb-2019

No. of pages : 123

PRICE
3480
6960

  • Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.

    Scope of the Report:
    The global average price of Polio Vaccine is in the increasing trend, from 497 USD/K doses in 2012 to 534 USD/K doses in 2016. With the situation of global economy and the IPV more and more popular, prices will be in increasing trend in the following five years.
    The classification of Polio Vaccine includes Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV), and the revenue proportion of Inactivated Polio Vaccine (IPV) in 2016 is about 15.4%, and the proportion is in decreasing trend from 2012 to 2016.
    The worldwide market for Polio Vaccine is expected to grow at a CAGR of roughly 5.0% over the next five years, will reach 1630 million US$ in 2024, from 1210 million US$ in 2019, according to a new study.
    This report focuses on the Polio Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

    Market Segment by Manufacturers, this report covers
    Sanofi
    GSK
    Bibcol
    Serum Institute
    Tiantan Biological
    IMBCA
    Panacea Biotec Ltd
    Bio-Med
    Halfkin Bio-Pharmaceuticals

    Market Segment by Regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    South America (Brazil, Argentina, Colombia etc.)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

    Market Segment by Type, covers
    Inactivated Polio Vaccine (IPV)
    Oral Polio Vaccine (OPV)

    Market Segment by Applications, can be divided into
    Public
    Private

    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Polio Vaccine product scope, market overview, market opportunities, market driving force and market risks.
    Chapter 2, to profile the top manufacturers of Polio Vaccine, with price, sales, revenue and global market share of Polio Vaccine in 2017 and 2018.
    Chapter 3, the Polio Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Polio Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
    Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
    Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
    Chapter 12, Polio Vaccine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
    Chapter 13, 14 and 15, to describe Polio Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports